Skip to main content
Login
Contact
Subscribe
Search form
Search
The Kane Republican
Home
Forms
News
Sports
Classifieds
Obituaries
Entertainment
Special Sections
Talking About...
Photos
Videos
Games
Community Links
KADC
Kane Area High School
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Amneal Pharmaceuticals Inc
(NY:
AMRX
)
3.560
USD
-0.120 (-3.26%)
Official Closing Price
/ Updated:
6:55 PM EST, Dec 9, 2019
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
1,551,500
Open
3.750
Bid (Size)
3.500 (10)
Ask (Size)
8.290 (1)
Prev. Close
3.680
Today's Range
3.550 - 3.760
52wk Range
2.270 - 17.46
Shares Outstanding
N/A
Dividend Yield
N/A
Performance
YTD
-74.75%
-74.75%
1 Month
+34.34%
+34.34%
3 Month
+18.67%
+18.67%
6 Month
-53.71%
-53.71%
1 Year
-78.92%
-78.92%
Top News
More News
Amneal Announces the Approval and Launch of Generic Carafate®
December 03, 2019
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), today announced that it has received final U.S. Food and Drug Administration approval on its Abbreviated New Drug Application for a generic version of...
Read More
from
Business Wire News Releases
Amneal Announces the Approval and Launch of Generic Revatio® for Oral Suspension and Generic Amicar® Tablets
December 02, 2019
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), today announced that it has received final U.S. Food and Drug Administration (“FDA”) approval on its Abbreviated New Drug Applications (“ANDA”) for generic...
Read More
from
Business Wire News Releases
More News
Read More
Amneal Pharmaceuticals to Present at the Piper Jaffray 31st Annual Healthcare Conference
November 26, 2019
from
Business Wire News Releases
Analysts Forecast 15% Gains Ahead For IHE
November 27, 2019
category
ETFs
from
ETF Channel
Pharma Companies Shares Tank As Feds Investigate Opioid Crisis
November 27, 2019
category
WSJ
,
General
,
TEVA
, and 14 more.
from
Benzinga
Possible criminal probe undermines recovery in opioid stocks since global legal settlement announced
November 27, 2019
category
Financial Services
,
MNK
,
AMRX
, and 6 more.
from
MarketWatch
PRESS DIGEST- Wall Street Journal - Nov 27
November 27, 2019
category
companyNews
from
Reuters: Company News
UPDATE 3-U.S. prosecutors open criminal probe of opioid makers, distributors
November 26, 2019
category
companyNews
from
Reuters: Company News
UPDATE 2-Federal prosecutors open criminal probe of opioid makers, distributors -WSJ
November 26, 2019
category
companyNews
from
Reuters: Company News
UPDATE 1-Federal prosecutors open criminal probe of opioid makers, distributors -WSJ
November 26, 2019
category
companyNews
from
Reuters: Company News
Federal prosecutors open criminal probe of opioid makers, distributors - WSJ
November 26, 2019
category
companyNews
from
Reuters: Company News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.